Western Australian Psychotropic Drugs Committee - WAPDC

Guidelines and Information


Anxiety Disorders (August 2008)

Requests for printed copies of the Anxiety Disorders guidelines can be placed using the WA Health Online Catalogue or by phoning HealthInfo on 1300 135 030


Back to Top

Antidepressants (January 2005)

Includes sections on:

  • Guidelines for the drug treatment of depression
  • Algorithm for pharmacotherapy of depression
  • Clinical conditions influencing selection of antidepressants
  • Switching antidepressant agents
  • Adverse effects that influence selection of antidepressants
  • Clinically relevant drug interactions with newer antidepressants

Back to Top

Antipsychotic Drug Guidelines (August 2006)

Antipsychotic Drug Guidelines [PDF 440KB]
Version 3 of the 2006 Antipsychotic Drug Guidelines includes sections on,

  • Antipsychotic therapy in clinical practice
  • Oral therapy and monitoring
  • Depot antipsychotic therapy
  • Antipsychotic-induced cardiac arrhythmia
  • Pharmacological management of acute arousal

Printed copies are also available by contacting WATAG.


Back to Top

Sedation of Acutely Agitated Adult Patients Prior to Transportation (January 2006)

Sedation Guidelines [PDF 580KB] were developed by WAPDC in conjunction with the RFDS (WA) to guide the management of acutely agitated adult patients prior to transportation, particularly in rural and remote areas.

Printed copies are also available by contacting WATAG.


Back to Top

Pharmacological Management of Acutely Aroused Adult Patients (March 2007)

Acute Arousal Guidelines [PDF 158KB] were developed by WAPDC as a to guide the management of acutely agitated general medical patients.

Printed copies are also available by contacting WATAG.


Back to Top

Advisory Notes


Back to Top

Graylands Hospital Drug Bulletin


Main Topic Vol. No. Month Year

Metabolic Syndrome, Prolactin Elevation

16

2

June

2009

Desvenlafaxine and Duloxetine: new antidepressants

16

1

March

2009

Antidepressant combination and augmentation 15 4 October 2008
Paliperidone 15 4 June 2008
Antipsychotic Combinations 15 3 February 2008
Smoking Cessation in Psychiatric Patients 15 2 July 2007
Ziprasidone Unzipped 15 1 March 2007
CATIE and Typical Antipsychotics 14 4 December 2006
Antipsychotic Monitoring 14 3 October 2006
Psychotropic drug interactions 14 2 July 2006
Antipsychotic switching: When, how, why? 14 1 March 2006
Management of clozapine-induced side-effects 13 4 December 2006
Treatment of antipsychotic-induced weight gain 13 3 October 2005
New Anticonvulsants as Mood Stabilisers 13 2 June 2005
Metabolic disturbances with antipsychotics 13 1 March 2005
Lithium revisited – frequently asked questions 12 4 December 2004
Clozapine & gastrointestinal adverse effects 12 3 September 2004
Atomoxetine – how useful for ADHD? 12 2 July 2004
Clozapine augmentation 12 1 March 2004
Aripiprazole – a new class of antipsychotic? 11 4 November 2003
Lithium induced hypothyroidism. When to treat? 11 3 June 2003
Risperdal Consta 11 2 May 2003
Combining antidepressants 11 1 February 2003
Reboxetine – a'NaRI' 10 3 November 2002
Profile of amisulpride 10 2 July 2002


Back to Top

File Formats
The documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.

Get Adobe® Reader